Puerto Vallarta News
Puerto Vallarta News

The most local news coverage in Puerto Vallarta

Mexico approves bimonthly Cabotegravir

Mexico approves Cabotegravir injection for bimonthly PrEP – HIV prevention

Mexico’s health regulator has authorized long-acting cabotegravir for pre-exposure prophylaxis (PrEP), moving HIV prevention from a daily pill to six injections a year administered by healthcare personnel. The authorization notes a possible lead-in with oral tablets or an initial monthly injection phase before switching to every-eight-week dosing.

Cofepris framed the decision inside its July update of health authorizations—210 in total, including 164 medical devices, 28 medicines, and 18 clinical research protocols. Among the medicines, cabotegravir stands out for offering continuous protection with bimonthly application.

Cabotegravir PrEP Mexico

Cabotegravir is an integrase inhibitor; by blocking the virus’s integrase enzyme, it prevents HIV from inserting its genetic material into human DNA, a necessary step to establish infection. That mechanism underpins the medicine’s extended-release formulation and the every-two-months dosing after initiation.

The approval aligns with global evidence. In the HPTN 083 trial among cisgender men and transgender women, injectable cabotegravir was superior to daily TDF/FTC at preventing HIV acquisition. A companion trial, HPTN 084, found superior protection in cisgender women as well. These findings helped shape international guidance.

Routine HIV testing at every injection visit is central to safe use. If someone acquires HIV and continues receiving cabotegravir unknowingly, the virus can develop resistance to this drug class. That’s why clinics pair the schedule with testing and follow-up.

From authorization to access

Regulatory clearance is a starting line, not the finish. Public access will depend on procurement, clinic training, supply logistics, and appointment tracking so people can keep the eight-week rhythm that makes long-acting PrEP work. The bimonthly schedule can ease adherence for those who struggle with daily pills or face stigma around taking them—one reason the World Health Organization recommends offering cabotegravir as an additional, highly effective prevention option.

Mexico’s move puts a proven tool into the prevention toolkit. With cabotegravir PrEP Mexico, the promise is fewer missed doses, stronger protection shown in trials, and care pathways designed around regular clinic touchpoints. The outcome—lower new infections—will come down to how quickly and equitably health services can turn this authorization into appointments, injections, and sustained prevention on the ground.

Related Posts

Peso Breaks 19 in Puerto Vallarta

Mexican Peso Closes Above 19 for First Time Since 2025

Mexico's peso closed at 19.1182 per dollar after a second day of losses. Banxico's minutes...
PVDN LGBTQ Council Rebukes Officials

Vallarta Officials Skipped LGBTQ Meetings and Got Called Out

Puerto Vallarta's LGBTQ council censures absent city representatives after repeated missed meetings, demanding written explanations...
PVDN_ U.S. Fugitive Arrested in Jalisco

Second U.S. Fugitive Caught in Jalisco Child Abuse Probe

Jalisco police arrest a U.S. fugitive sought in a child abuse case. Authorities allege links...
Vallarta Neighborhoods Without Water

Broken Water Pipe Leaves 17 Vallarta Neighborhoods Dry

A broken water pipe cuts service to 17 El Pitillal neighborhoods. SEAPAL expects water to...